| Identification | Back Directory | [Name]
CP-810123 | [CAS]
439608-12-5 | [Synonyms]
CP-810123
UNII-E6G4550EC4
1,4-Diazabicyclo[3.2.2]nonane, 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-
2-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-5-methyl-[1,3]oxazolo[4,5-b]pyridine | [Molecular Formula]
C14H18N4O | [MDL Number]
MFCD18251529 | [MOL File]
439608-12-5.mol | [Molecular Weight]
258.32 |
| Hazard Information | Back Directory | [Uses]
CP-810123 is a brain-permeable agonist of α7 nAChR for the research of cognitive impairment associated with psychiatric or neurological disorders such as schizophrenia and Alzheimer's disease[1]. | [References]
[1] Jun Toyohara, et al. α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer’s Disease. Open Med Chem J. 2010; 4: 37–56. |
|
| Company Name: |
SPIRO PHARMA
|
| Tel: |
|
| Website: |
www.spiropharma.com.cn |
|